Literature DB >> 23690230

Effect of acute and chronic administration of L-tyrosine on nerve growth factor levels in rat brain.

Gabriela K Ferreira1, Isabela C Jeremias, Giselli Scaini, Milena Carvalho-Silva, Lara M Gomes, Camila B Furlanetto, Meline O Morais, Patrícia F Schuck, Gustavo C Ferreira, Emilio L Streck.   

Abstract

Most inborn errors of tyrosine catabolism produce hypertyrosinemia. Neurological manifestations are variable and some patients are developmentally normal, while others show different degrees of developmental retardation. Considering that current data do not eliminate the possibility that elevated levels of tyrosine and/or its derivatives may have noxious effects on central nervous system development in some patients, the present study evaluated nerve growth factor (NGF) levels in hippocampus, striatum and posterior cortex of young rats. In our acute protocol, Wistar rats (10 and 30 days old) were killed 1 h after a single intraperitoneal administration of L-tyrosine (500 mg/kg) or saline. Chronic administration consisted of L-tyrosine (500 mg/kg) or saline injections 12 h apart for 24 days in Wistar rats (7 days old); the rats were killed 12 h after the last injection. NGF levels were then evaluated. Our findings showed that acute administration of L-tyrosine decreased NGF levels in striatum of 10-day-old rats. In the 30-day-old rats, NGF levels were decreased in hippocampus and posterior cortex. On the other hand, chronic administration of L-tyrosine increased NGF levels in posterior cortex. Decreased NGF may impair growth, differentiation, survival and maintenance of neurons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23690230     DOI: 10.1007/s11064-013-1078-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  Development of the cerebral cortex in rodents and man.

Authors:  H B Uylings
Journal:  Eur J Morphol       Date:  2000-12

Review 2.  Physiology of nerve growth factor.

Authors:  H Thoenen; Y A Barde
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

Review 3.  The nerve growth factor 35 years later.

Authors:  R Levi-Montalcini
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

Review 4.  Neurotrophin signal transduction in the nervous system.

Authors:  D R Kaplan; F D Miller
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

5.  Tyrosine uptake and regional brain monoamine metabolites in a rat model resembling congenital hyperammonemia.

Authors:  J P Colombo; C Bachmann; H Cervantes; M Kokorovic; R Perritaz
Journal:  Pediatr Res       Date:  1996-06       Impact factor: 3.756

6.  Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing.

Authors:  Alessandra Micera; Alessandro Lambiase; Ilaria Puxeddu; Luigi Aloe; Barbara Stampachiacchiere; Francesca Levi-Schaffer; Sergio Bonini; Stefano Bonini
Journal:  Exp Eye Res       Date:  2006-05-23       Impact factor: 3.467

7.  Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat.

Authors:  Rodolfo Bongiovanni; Bryan K Yamamoto; Catherine Simpson; George E Jaskiw
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

8.  Regional tyrosine levels in rat brain after tyrosine administration.

Authors:  M C Morre; F Hefti; R J Wurtman
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

9.  Nerve growth factor (NGF) in the rat CNS: absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra.

Authors:  M E Schwab; U Otten; Y Agid; H Thoenen
Journal:  Brain Res       Date:  1979-06-08       Impact factor: 3.252

10.  Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.

Authors:  M Seiler; M E Schwab
Journal:  Brain Res       Date:  1984-05-21       Impact factor: 3.252

View more
  8 in total

1.  Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Samira Dal-Toé de Prá; Leticia B Wessler; Patricia F Schuck; Giselli Scaini; Andreza Fabro de Bem; Carlos H Blum-Silva; Flávio H Reginatto; Jade de Oliveira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-11-08       Impact factor: 3.584

2.  Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Joyce Rebelo; Adriani P Damiani; Maiara Pereira; Vanessa M Andrade; Fernanda F Gava; Samira S Valvassori; Patricia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-03-18       Impact factor: 3.584

3.  Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine.

Authors:  Brena P Teodorak; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Letícia J Teixeira; Joyce Rebelo; Samira D T De Prá; Neila Zeni; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-12-06       Impact factor: 3.584

4.  The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility.

Authors:  Gabriela K Ferreira; Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Leticia J Teixeira; Isabella T Mota; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-09-25       Impact factor: 3.584

5.  Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Maria L Gomes; Bruna K Ferreira; Patricia F Schuck; Gustavo C Ferreira; Felipe Dal-Pizzol; Jade de Oliveira; Giselli Scaini; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-04-04       Impact factor: 3.584

6.  Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II.

Authors:  Emilio L Streck; Samira D T De Prá; Paula Ronsani Ferro; Milena Carvalho-Silva; Lara M Gomes; Jotele F Agostini; Adriani Damiani; Vanessa M Andrade; Patrícia F Schuck; Gustavo C Ferreira; Giselli Scaini
Journal:  Mol Cell Biochem       Date:  2017-05-25       Impact factor: 3.396

7.  Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats.

Authors:  Lara M Gomes; Giselli Scaini; Milena Carvalho-Silva; Maria L Gomes; Fernanda Malgarin; Luiza W Kist; Maurício R Bogo; Eduardo Pacheco Rico; Alexandra I Zugno; Pedro F P Deroza; Gislaine Z Réus; Airam B de Moura; João Quevedo; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2018-02-07       Impact factor: 3.911

8.  Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine.

Authors:  Rafaela Antonini; Giselli Scaini; Monique Michels; Mariane B D Matias; Patrícia F Schuck; Gustavo C Ferreira; Jade de Oliveira; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-12-11       Impact factor: 3.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.